WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001081393) A NOVEL POLYPEPTIDE - HUMAN YSK1 PROTEIN KINASE 20 AND A POLYNUCLEOTIDE SEQUENCE ENCODING THE SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/081393    International Application No.:    PCT/CN2001/000597
Publication Date: 01.11.2001 International Filing Date: 23.04.2001
IPC:
C12N 9/12 (2006.01)
Applicants: BIOWINDOW GENE DEVELOPMENT INC. SHANGHAI [CN/CN]; 3rd Building 12th floor 1111 Zhongshan Bei Er Road Shanghai 200092 (CN) (For All Designated States Except US).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: WATSON & BAND LAW OFFICES; 11th Floor 61 Nanjing Road (E) Shanghai 200002 (CN)
Priority Data:
00 1 15467.2 27.04.2000 CN
Title (EN) A NOVEL POLYPEPTIDE - HUMAN YSK1 PROTEIN KINASE 20 AND A POLYNUCLEOTIDE SEQUENCE ENCODING THE SAME
(FR) NOUVEAU POLYPEPTIDE, PROTEINE KINASE YSK1 HUMAINE 20, ET POLYNUCLEOTIDE CODANT POUR CE POLYPEPTIDE
Abstract: front page image
(EN)The present invention discloses a novel polypeptide - human YSK1 protein kinase 20 and a polynucleotide encoding the same, as well as a method of producing the polypeptide by DNA recombinant technique. The present invention also discloses methods of using the polypeptide in treatment of various disease, such as malignant tumor, blood disease, developmental disturbance, HIV infection, immunological disease, various inflammation and so on. The present invention also discloses an antagonist against the polypeptide and the therapeutic use of the same. Also disclosed is the use of such novel polynucleotide encoding human YSK1 protein kinase 20.
(FR)L'invention concerne un nouveau polypeptide, une protéine kinase YSK1 humaine 20, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des tumeurs malignes, de l'hémopathie, des troubles du développement, de l'infection par VIH, de maladies immunitaires et de diverses inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la protéine kinase YSK1 humaine 20.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)